Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
Conditions: Overweight; Obesity Interventions: Other: Low-carbohydrate Diet; Other: Low-fat Diet Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Closed Loop and Education for Hypoglycemia Awareness Restoration
Conditions: Diabetes Mellitus, Type 1 Interventions: Device: Omnipod 5 or Medtronic 780G; Behavioral: My HypoCOMPaSS Education; Behavioral: HARPdoc Education Sponsors: Milton S. Hershey Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Minnesota; University of Kentucky; University of Pennsylvania; University of California, San Diego; AdventHealth; University of Leicester; University of Sheffield; University of Melbourne; Jaeb Center for Health Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Conditions: Type 2 Diabetes Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Cohort Study on Plant-based Diets (COPLANT Study)
Conditions: Dietary Exposure; Diabetes Mellitus, Type 2; Cardiovascular Diseases; Bone Loss; Sustainability; Exposure; Obesity; Vitamin Deficiency; Mineral Deficiency Sponsors: German Federal Institute for Risk Assessment; Max Rubner-Institut; University of Bonn; Research Institute for Plant-Based Nutrition; University of Jena; University of Regensburg; Heidelberg University; University of Vienna Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Conditions: Type 2 Diabetes Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Interactive virtual assistance for mental health promotion and self-care management in elderly with type 2 diabetes (IVAM-ED): study protocol and statistical analysis plan for a randomized controlled trial
This study assesses the effectiveness of an interactive virtual assistance system for enhancing mental health and glycemic control among elderly individuals with type 2 diabetes. The findings may introduce smart speakers as a valuable tool for promoting diabetes-related self-care in this population.Trial registrationClinicalTrials.gov NCT05329376. Registered on 15 April 2022. Enrollment began on 20 June 2023 and the last update of protocol was on 13 December 2023. (Source: Trials)
Source: Trials - March 21, 2024 Category: Research Source Type: clinical trials
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies
ConclusionFIONA is evaluating the use of finerenone in children with CKD and proteinuria. Should safety, tolerability, and efficacy be demonstrated, finerenone could become a useful additional therapeutic agent in managing proteinuria and improving kidney outcomes in children with CKD.Trial registrationClinicalTrials.gov NCT05196035. Registered on 19 January 2022. (Source: Trials)
Source: Trials - March 21, 2024 Category: Research Source Type: clinical trials
Effect of an entry-to-care intervention on diabetes distress in individuals with newly diagnosed type 2 diabetes: a study protocol for a cluster-randomized trial
ConclusionThis study is among the first clinical trials exploring the development of DD from diagnosis to 12 months post-diagnosis. Many previous interventions did not directly target DD as the primary outcome. This research provides new insights into DD progression in patients newly diagnosed with T2DM and examines an intervention designed to lower DD in early diabetes stages, contributing to a better u nderstanding of the development of DD and how this intervention affects patient well-being.Trial registrationClinicalTrial.gov NCT05571306. Registered on 07 October 2022. (Source: Trials)
Source: Trials - March 21, 2024 Category: Research Source Type: clinical trials
Examining the Feasibility of Wysa in Hindi
Conditions: Mental Health Issue; Diabetes Distress Interventions: Behavioral: Wysa in Hindi; Behavioral: Individual and group sessions on topics like motivation, coping, wellbeing Sponsors: Wysa; Udaan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Precision Medicine of Diabetes Program in China
Conditions: Diabetes Interventions: Other: no intervention Sponsors: Second Xiangya Hospital of Central South University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
Conditions: Diabetes Type 2 Interventions: Device: AI-assisted insulin dose adjustment model; Other: doctor ' s insulin dose adjustment Sponsors: Shanghai Zhongshan Hospital; Shanghai Fifth People ' s Hospital,Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Phase 2a Multi-Center, Prospective, Randomized Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects With Diabetic Foot Ulcers (DFU)
Conditions: Diabetic Foot Ulcer Interventions: Biological: PEP (Purified Exosome Product) / TISSEEL Sponsors: Rion Inc.; Professional Education and Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Preventing Obstetric Complications With Dietary Intervention
Conditions: Gestational Diabetes; Gestational Hypertension; High Risk Pregnancy; Preeclampsia Interventions: Behavioral: Maternal Health Management Program Sponsors: Medical College of Wisconsin; Advancing a Healthier Wisconsin Endowment; Food for Health, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
Conditions: Type 2 Diabetes Interventions: Behavioral: Diabetes Self-Management Education and Support (DSMES) Videos; Behavioral: Community Health Worker Support (CHW) Sponsors: NYU Langone Health; Agency for Healthcare Research and Quality (AHRQ) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Conditions: Diabetic Retinopathy Interventions: Drug: BI 764524; Drug: Sham comparator to BI 764524; Drug: Aflibercept (Eylea ®) - US only Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
